inTEST Corporation (INTT) Income Statement

Revenue fell sharply through 2025 with three consecutive quarters of YoY contraction before inflecting in late 2025. The recovery appears driven by broader semiconductor capex normalization rather than a structural shift in INTT's end-market position, given the historically volatile pattern (e.g., +39.9% in 2024Q4 followed by -10.3% in 2025Q4). The current upswing is encouraging but the mixed history suggests cyclicality rather than durable growth.

The margin dispersion is notable: peaks above 45% (2024Q3, 2025Q4) coincide with periods of lower revenue, suggesting favorable mix or favorable one-time factors rather than sustainable improvement. Conversely, higher-volume quarters like 2024Q4 ($36.6M) delivered only 39.7% gross margin, implying volume growth may come with adverse mix or discounting. Relative to peers, INTT's ~40-43% band sits below ACMR (44.4%) and far below NVEC (78.7%), consistent with its position in a lower-margin hardware-intensive niche.

SG&A has remained stubbornly in the $8.9M–$11.3M range regardless of revenue, indicating a largely fixed cost base that INTT has not scaled down through the downturn or up with the recovery. R&D has similarly held near $2.2–2.6M. The implication is that operating margin is almost entirely a function of gross profit dollars, leaving earnings highly sensitive to volume and mix — a structural vulnerability investors should monitor if semiconductor capex softens again.

The cost structure reveals that variable costs behave reasonably, but the fixed overhead layer (SG&A + R&D) sets an effective breakeven revenue threshold near $28–30M. In quarters below that level (2025Q1–Q3), INTT posted operating losses; above it, margins have compressed to single digits at best. The modest reduction in SG&A during the trough suggests limited near-term capacity for margin-accretive cost restructuring absent meaningful top-line expansion.